Re Dickinson Investment Advisors, LLC Amgen Inc Transaction History
Re Dickinson Investment Advisors, LLC
- $1.77 Billion
- Q4 2024
A detailed history of Re Dickinson Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Re Dickinson Investment Advisors, LLC holds 387 shares of AMGN stock, worth $121,665. This represents 0.06% of its overall portfolio holdings.
Number of Shares
387
Previous 2,152
82.02%
Holding current value
$121,665
Previous $693,000
45.6%
% of portfolio
0.06%
Previous 0.4%
Shares
3 transactions
Others Institutions Holding AMGN
# of Institutions
3,183Shares Held
418MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.6 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.5 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.25 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.58 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.15 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $168B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...